Sign in

CIK 0001398733

  • Non-accelerated filer
  • Smaller reporting company

Aquestive Therapeutics, Inc.

Sign in to watch
Ticker
AQST
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208623253
Phone
+1 908-941-1900
Business address
184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
Former names
MonoSol Rx, Inc.
  1. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 97 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy SVP, General Counsel bought 14,000 shares at $1.54 ($21,624)
  10. 4 Open-market buy SVP-Bus. Process & Info. Tech. bought 2,000 shares at $1.50 ($3,000)
  11. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 5,066 shares (to pay taxes)
  12. 4 Shares withheld for taxes CEO and President gave up 4,729 shares (to pay taxes)
  13. 4/A Shares withheld for taxes CEO and President gave up 149 shares (to pay taxes)
  14. 4/A Shares withheld for taxes Chief Innovation/Tech Officer gave up 147 shares (to pay taxes)
  15. 4/A Shares withheld for taxes CEO and President gave up 6,597 shares (to pay taxes)
  16. 4/A Shares withheld for taxes Chief Innovation/Tech Officer gave up 6,544 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 329 shares (to pay taxes)
  18. 4 Shares withheld for taxes CEO and President gave up 329 shares (to pay taxes)
  19. 4 Shares withheld for taxes CEO and President gave up 14,572 shares (to pay taxes)
  20. 4 Shares withheld for taxes Chief Innovation/Tech Officer gave up 14,572 shares (to pay taxes)

Page 12 of 17 · 326 filings